OTLK Equities

ROSEN, A Foremost Investor Counsel, Urges Outlook Therapeutics Shareholders to Act Before Class Action Deadline Dec 3, 2023

ROSEN, A Top Firm, Urges Outlook Therapeutics Investors to Act Prior to Securities Class Action Deadline - OTLK Dec 2, 2023

Investors Notified of Class Action Deadline for Outlook Therapeutics, Inc. OTLK Nov 20, 2023

ROSEN, A Top-Tier Investor Counsel, Urges Outlook Therapeutics Investors To Seek Legal Advice Ahead Of Class Action Deadline Nov 19, 2023